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abstract
Tilapia (Oreochromis mossambicus] teleostei) 
melanin-concentrating hormone gene-related peptide 
(tMgrp) was tested for tropic actions on 
adenocorticotropin hormone (ACTH) and a -  
melanocyte s t im u la t in g  ho rm one  ( a - M S H )  
producing cells in the tilapia pituitary gland in vitro. 
Up to 100 pM synthetic tilapia Mgrp (tMgrp) had 
no effect on a -M S H  release from tilapia neuro- 
intermediate lobes in a superfusion set up. However, 
at concentrations above 1 |_tM, tMgrp concentration 
dependently stimulated ACTH release from tilapia 
anterior lobes. This is the first evidence that Mgrp 
modulates ACTH release from teleost corticotropes, 
and this might implicate the peptide in the 
regulation of the pituitary-interrenal axis of fish.
INTRODUCTION
Melanin-concentrating hormone (MCH) was first 
d i s c o v e re d  in t e l e o s t e a n  f i s h e s  as a 
neurohypophysial hormone involved in the 
regulation of background adaptation. More recently 
a function in the regulation of the stress response 
has been attributed to this peptide in teleosts (Baker 
1991, Baker & Bird 1992, Groneveld et al. 1995a), 
and mammals (Baker 1994). Sequence analysis of 
MCH preprohormones of teleosts and mammals 
indicated that processing of the prohormone may 
yield more functional peptides besides MCH (Baker 
1991). Indeed, the actual processing of mammalian 
neuropeptide glutamic acid-isoleucine amide (NEI) 
(Parkes & Vale 1992) and of tilapia MCH gene- 
related peptide (tMgrp) (Groneveld et al. 1995c) 
from the M CH preprohormone has been
demonstrated. Both peptides directly precede MCH
t
in the prohormone. Tilapia Mgrp is very different 
Irom NEI in length (22 and 13 amino acids 
respectively), as well as in amino acid sequence
(Groneveld et al. 1993, 1995c), in contrast to MCH 
itself, which has been highly conserved during 
evolution. MCH and Mgrp are colocated in the 
hypothalamus and pituitary of tilapia (Groneveld et 
al. 1995c).
In teleosts, a modulatory action of M CH on 
pituitary melanotropes and corticotropes has been 
described [Baker 1991]. At physio logical 
concentrations MCH inhibits a -M S H  release from 
the pituitary of trout and tilapia, whereas at high 
concentrations MCH in vitro stimulates a -M S H  
release of tilapia (Barber et al. 1987, Groneveld et 
al. 1995b). For trout an inhibitory action of MCH 
on CRH stimulated ACTH release has been reported 
(Baker et al. 1985, 1986), which is assumed to 
result from an inhibitory action of M CH on the 
release of CRH (Baker 1994).
In mammals, the actions attributed to NEI 
are partly similar to, and partly different from that 
of MCH (Parkes & Vale 1993, Baker 1994). 
However, the function of tMgrp is still unclear. In a 
previous study it was shown that tMgrp has no 
effect on pigment dispersion of tilapia scale 
melanophores in vitro, and that it does not interfere 
with the pigment concentrating action of MCH 
(Groneveld et al. 1995c). The question arises 
whether tMgrp, like MCH, exhibits effects at the 
pituitary level. Therefore, in the present study 
effects of synthetic tMgrp on a -M S H  and ACTH 
release from the tilapia pituitary gland were 
investigated using an in vitro superfusion set up.
MATERIALS & METHODS
Animals
Male tilapia (Oreochromis mossambicus), ranging 
from 15 to 25 g, were bred in the aquarium facility 
of the Dept, of Animal Physiology of the University 
of Nijmegen. They were kept in fresh water at 28°C 
and were fed a commercial dried fish food
burnal o f  Endocrinology (1996) 148, R1-R4 (C) 1996 Journal of Endocrinology Ltd Printed in Great Britain 
0022 -0 7 9 5 /9 6 /0 147-00RI $08.00/0 Accepted 14 November 1995
Rapid communications
(Tetramin). The fish were kept in glass aquaria, 
illuminated by overhead TL tubes, with a day-night 
rhythm of 12 h light and 12 h darkness. 
Immediately after removal from the tank (9.00 h; 2h 
after light on), the animals were sacrificed by spinal 
transection, pituitary glands were dissected from the 
brain, and neurointermediate lobes (NILs) and 
anterior lobes (ALs) were separated.
Superfusion of pituitary tissue
Freshly dissected NILs or ALs were superfused as 
described before (Groneveld et al. 1995b). 100 pi 
chambers were superfused at 30 pl/min. Pulses (30 
min) were given with 1 nM to 100 pM synthetic 
tMgrp (Groneveld et al. 1995c). Synthetic tMgrp 
was synthesized at the Department of Organic 
Chemistry of our university by solid phase peptide 
synthesis using the Fmoc strategy for cleavage (see 
Chang & Meienhofer, 1978 for details). Controls, 
which were superfused simultaneously, received 
incubation medium (142 mM NaCl, 2mM KC1, 2 
m M  CaCl2, 15 mM HEPES (pH 7.38), 0.3 mg/ml 
bovine serum albumin (Sigma), 2.5 mg/ml glucose) 
without tMgrp. In a typical experiment, 3 groups 
(controls and 2 Mgrp doses; usually n=6 each) were 
incubated. The collected superfusion fractions were 
immediately frozen and stored at -20°C until a -  
MSH or ACTH radioimmunoassay.
Radioimmunoassays
The a -M S H  radioimmunoassay (RIA) with L9 a -  
M S H  a n t i s e r u m ,  w h ic h  sh o w s  n e g l ib le  
crossreactivity with ACTH|.3y, has been described 
previously (Balm et al. 1995). The RIA for ACTH 
using an antiserum against ACTH,_24 also has been 
described previously (Balm et al. 1994). a -M SH  is 
not detected by this assay; the a -M S H  and ACTH 
antisera did not crossreact with tMgrp.
secretagogue. The presented values for maximum 
stimulation were corrected for the increasing in vitro 
unstimulated release of ACTH (Balm et al. 1994) by 
subtraction of the maximum increase of the controls. 
The difference between maximum stimulation in the 
tMgrp pulsed lobes and in controls during the same 
period was statistically analyzed. Statistical analyses 
were performed using the unpaired Student’s t test. 
Significance was accepted at P < 0.05.
RESULTS
Effects of tMgrp on ACTH and a-M SH release
The stimulatory effect of tMgrp on the ACTH 
release from tilapia ALs during in vitro superfusion 
lasted for the duration of the pulse; after the pulse 
ACTH release returned to control levels (Fig. 1). At 
a concentration of 1 jjM tMgrp tended to stimulate 
ACTH release, although at this concentration the 
stimulation was not statistically significant (P > 0.1). 
At 10 and 100 |oM tMgrp caused a significant 
stimulation of ACTH release, which was most
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Processing of data and statistics
For the concentration response relationship of 
tMgrp-induced effects on ACTH and a -M SH  
release, values for maximum stimulation of ACTH 
or a -M S H  release during the tMgrp pulse were 
calculated by subtracting the basal release value 
from the maximum pulse values for each incubation. 
Basal release was defined as the average hormone 
release in 20 to 30 min prior to addition of
journal o f Endocrinology (1996) 148, R1 R4
Figure 1 Effect of 10 |j M synthetic tMgrp on
ACTH release from tilapia ALs during in vitro 
superfusion expressed as percentage of basal release (= 
100%). tMgrp, n = 8 , basal release 3.06 ± 0.57 
pg/min/AL; -O-, control, n = 4, basal release 4.15 ± 0.46 
pg/min/AL. The time of addition of secretagogue after 
400 min of superfusion is designated t(). * P < 0.05 
compared with the corresponding fraction of control 
superfusion.
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Figure 2 Effects of synthetic tMgrp on ACTH
release from ALs and a-M SH release from NILs taken 
from the same fish, during in vitro superfusion. Data are 
expressed as maximum stimulation during tMgrp pulse 
vs. basal release minus maximum "stimulation" in control 
superfusion. Numbers of incubations (are given in 
parentheses for each concentration tested. A. 
Concentration response relationship of tMgrp induced 
effects on ACTH release. Basal release was 2.05 ± 0 .1 5  
pg/min/AL (n = 81). **, P < 0.01 compared with control 
superfusion. B. Concentration response relationship of 
tMgrp induced effects on a-M SH release. Basal release 
was 6.67 ± 0.64 pg/min/NIL (n = 43).
pronounced at 100 jjM  (Fig. 2A). Concentrations 
lower than 1 pM had no effect. Tilapia Mgrp, at 
concentrations from 1 nM to 100 (j M, had no effect 
on a -M S H  release of tilapia NILs (Fig. 2B). At all 
concentrations tested no statistically significant 
differences in a -M S H  release occurred between 
tMgrp-pulsed and control lobes.
DISCUSSION
The observed stimulatory effect of synthetic tMgrp 
on ACTH release is the first demonstration that a 
te leost  pep tide  der ived  from the M C H  
preprohormone, other than MCH itself, regulates 
ACTH release at the level of the pituitary. In the 
course of this study it was reported that in rats i.c.v. 
NEI abolished the MCH-induced inhibition of 
ACTH plasma levels in response to an ether stress 
(Bluet-Pajot et al. 1995). Whether tMgrp exerted a 
direct effect on the corticotropes, or a presynaptic 
effect on nerve terminals, which in teleosts innervate 
the endocrine cells, remains to be established. At 
least two lines of evidence can be advanced that 
native tMgrp will show the same bioactivity as 
synthetic tMgrp. Firstly, the amino acid sequence of 
synthetic tMgrp was based on the sequence deduced 
from native preproMCH mRNA, and secondly the 
HPLC retention times of native tMgrp in pituitary 
and hypothalamus extracts and of the synthetic 
peptide were identical (Groneveld et al. 1995c). The 
influence of tMgrp on tilapia corticotropes implies 
the involvement of a novel component of the MCH- 
system in stress response. By preproMCH mRNA 
expression studies (Groneveld et al. 1995a), studies 
on newly synthesized MCH (Baker & Bird 1992) 
and plasma MCH measurements (Green et al. 1991, 
Green & Baker 1991) it was previously 
demonstrated that the MCH system is responsive to 
stress. However, knowledge on the sites of action of 
MCH preprohormone-derived peptides on the 
hypothalamus-pituitary-interrenal (HPI) axis is 
limited. In trout MCH has, besides its effect on 
CRH-induced ACTH release (Baker et al. 1985, 
1986), no effect on cortisol release from trout 
interrenal tissue (Green et al. 1991). The effect of 
MCH on melanotropes in both trout (Baker et al. 
1986, Barber et al. 1987) and tilapia (Groneveld et 
al. 1995b) may be an additional mechanism of 
action of the peptide on the HPI axis (Lamers et al. 
1992, Balm et al. 1995).
The doses of tMgrp required for the 
modulation of ACTH release may be indicative for a 
paracrine  or synaptic  action. M ic ro m o la r  
concentrations of tMgrp can only be expected in the 
vicinity of the tMgrp nerve terminals, where the 
peptide is released. Evidence for the contention that 
high peptide concentrations may actually arise, 
comes from structural studies (Batten & Baker
journal o f Endocrinology (1996) 148, R1-R4
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1988). This would be consistent with dose response 
curves of other secretagogues, such as MCH 
(Groneveld et al. 1995b), and GAB A (Verburg-van 
Kemenade et al. 1986) on a -M SH  release in lower 
vertebrates. However, comparison of cellular 
sensitivity of tilapia melanotropes in vitro to various 
secretagogues is hampered by the lack of 
homologous peptides, such as CRH, and the fact 
that information regarding the site of release forc c
several of these compounds is not available.
The effects of Mgrp on ACTH release in 
tilapia are opposite to the inhibitory action of MCH 
on CRH stimulated ACTH release from trout 
pituitaries (Baker et al. 1985). The action in trout is 
consistent with the idea that in this species MCH 
forms part of a feedback loop, modulating CRH 
secretion and the HPI axis (Baker 1994). Whether 
these differences relate to species (trout-tilapia) or 
peptide (MCH-Mgrp) differences cannot be resolved 
at present. In addition, the route of administration 
and the time of day may also be a major 
determinant of the effect of MCH and Mgrp on the 
parameters studied (Bluet-Pajot et al. 1995). Since 
MCH gene expression in teleosts also seems to be 
subject to diurnal rhythmicity (Suzuki et al. 1995), it 
may well be that tilapia corticotrope Mgrp 
sensitivity varies with the time of day.
The lack of effect of 1 nM to 100 jjM 
tMgrp on a -M S H  release contrasts with the 
inhibition of a -M S H  induced by MCH at low 
concentrations, and the stimulation at high
c
concentrations of M CH (Barber et al. 1987, 
Groneveld et al. 1995b). A possible explanation for 
this difference would be that pituitary melanotropes 
of tilapia have receptors for MCH but not for Mgip. 
These findings together with the previously reported 
lack of effect of tMgrp on tilapia scale 
melanophores (Groneveld et al. 1995c) indicate that 
in tilapia Mgrp by itself does not exert a direct, nor 
an indirect function in the regulation of background 
adaptation. However, it cannot be ruled out that 
tMgrp, which is co-released with MCH (Groneveld 
et al. 1995c), influences the action of MCH on 
pituitary targets.
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